Archive

Using AI to create better, more potent medicines

Written by Charlie King | 2 Jun 2023

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence… read more.

Journal of Pharmaceutical Analysis studies shine the light on advancements in pharmaceutical analytical techniques and overcoming chemoresistance

Written by Charlie King | 1 Jun 2023

Research into new drug development is ongoing at a very fast pace globally. In keeping with newer remedies entering the market, there is a need for optimizing existing… read more.

Artificial intelligence in pharmaceutical sciences revolutionizes drug research and development

Written by Charlie King | 27 May 2023

Scientists have long been challenged by the complex process of drug discovery and development, with investments that often go unrewarded. However, with the advancement of experimental technology and… read more.

Tadalafil shows potential as a diabetes treatment

Written by Bruce Sylvester | 17 May 2023

In a small feasibility study, subjects with type 2 diabetes achieved significant improvement in long-term blood sugar levels following treatment with high-dose tadalafil, an erectile dysfunction drug. Tadalafil… read more.

Atogepant shows efficacy for prevention of migraine

Written by Bruce Sylvester | 14 May 2023

Atogepant, an oral drug approved in the US for the prevention of episodic migraine treatment appears to also be effective for the prevention of chronic migraine. The findings of… read more.

Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn

Written by Charlie King | 12 May 2023

Most antidepressants used for chronic pain are being prescribed with “insufficient” evidence of their effectiveness, scientists have warned. A major investigation into medications used to manage long-term pain… read more.

Diabetes drugs associated with fewer adverse cardiac events

Written by Charlie King | 11 May 2023

GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older… read more.

Potency drug reduced long-term blood sugar in type 2 diabetes

Written by Charlie King | 8 May 2023

A small group of patients with type 2 diabetes significantly improved their long-term blood sugar levels when treated with high-dose tadalafil, a medication used to treat erectile dysfunction. The… read more.

Diabetes drug shows promise for “blinding headache” condition

Written by Bruce Sylvester | 23 Apr 2023

Exenatide, an injectable treatment for type 2 diabetes, has shown efficacy for the treatment of ‘blinding’ headaches known as idiopathic intercranial hypertension (IIH). Researchers from a phase 2… read more.

A 21st-century remedy for missed meds

Written by Charlie King | 17 Apr 2023

Missing crucial doses of medicines and vaccines could become a thing of the past thanks to Rice University bioengineers’ next-level technology for making time-released drugs. “This is a… read more.

New insights into an old drug: Scientists discover why aspirin works so well

Written by Charlie King | 2 Apr 2023

New research has revealed important information about how aspirin works. Even though this drug has been available commercially since the late 1800s, scientists have not yet fully elucidated… read more.

Study determines most effective ways for hospitals to reduce medication errors

Written by Charlie King | 24 Mar 2023

A new study from researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, has shed new light on the best strategies hospitals can… read more.

« Previous 1 2 3 4 5 Next »

Archive

Subscribe for our mailing list

Follow Us